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Outcomes and reoperations after total correction of complete
atrio-ventricular septal defect
Abstract
BACKGROUND: Surgical correction of complete atrio-ventricular septal defect (AVSD) achieves
satisfactory results with low morbidity and mortality, but may require reoperation. Our recent operative
results at mid-term were followed-up. METHODS: From June 2000 to December 2007, 81 patients
(Down syndrome; n=60), median age 4.0 months (range 0.7-118.6) and weight 4.7kg (range 2.2-33),
underwent complete AVSD correction. Patch closure for the ventricular septal defect (VSD; n=69) and
atrial septal defect (ASD; n=42) was performed with left atrio-ventricular valve (LAVV) cleft closure
(n=76) and right atrio-ventricular valve (RAVV) repair (n=57). Mortality, morbidity, and indications for
reoperation were retrospectively studied; the end point 'time to reoperation' was analyzed using
Kaplan-Meier curves. Follow-up was complete except in two patients and spanned a median of 28
months (range 0.4-6.1 years). RESULTS: In-hospital mortality was 3.7% (n=3) and one late death
occurred. Reoperation was required in 7/79 patients (8.9%) for LAVV insufficiency (n=4), for a residual
ASD (n=1), for right atrio-ventricular valve insufficiency (n=1), and for subaortic stenosis (n=1). At last
follow-up, no or only mild LAVV and RAVV insufficiency was present in 81.3% and 92.1% of patients,
respectively, and 2/3 of patients were medication-free. Risk factors for reoperation were younger age
(<3 months; p=0.001) and lower weight (<4kg; p=0.003), and a trend towards less and later reoperations
in Down syndrome (p<0.2). CONCLUSIONS: Surgical correction of AVSD can be achieved with low
mortality and need for reoperation, regardless of Down syndrome or not. Immediate postoperative
moderate or more residual atrio-ventricular valve insufficiency will eventually require a reoperation, and
could be anticipated in patients younger than 3 months and weighing <4kg.
www.elsevier.com/locate/ejcts
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mortality, butmay require reoperation. Our recent operative results at mid-termwere followed-up.Methods: From June 2000 to December 2007,
81 patients (Down syndrome; n = 60), median age 4.0 months (range 0.7—118.6) and weight 4.7 kg (range 2.2—33), underwent complete AVSD
correction. Patch closure for the ventricular septal defect (VSD; n = 69) and atrial septal defect (ASD; n = 42) was performed with left atrio-
ventricular valve (LAVV) cleft closure (n = 76) and right atrio-ventricular valve (RAVV) repair (n = 57). Mortality, morbidity, and indications for
reoperation were retrospectively studied; the end point ‘time to reoperation’ was analyzed using Kaplan—Meier curves. Follow-up was complete
except in two patients and spanned a median of 28 months (range 0.4—6.1 years). Results: In-hospital mortality was 3.7% (n = 3) and one late
death occurred. Reoperation was required in 7/79 patients (8.9%) for LAVV insufficiency (n = 4), for a residual ASD (n = 1), for right atrio-
ventricular valve insufficiency (n = 1), and for subaortic stenosis (n = 1). At last follow-up, no or onlymild LAVVand RAVV insufficiency was present
in 81.3% and 92.1% of patients, respectively, and 2/3 of patients weremedication-free. Risk factors for reoperationwere younger age (<3months;
p = 0.001) and lower weight (<4 kg; p = 0.003), and a trend towards less and later reoperations in Down syndrome ( p < 0.2). Conclusions:
Surgical correction of AVSD can be achieved with low mortality and need for reoperation, regardless of Down syndrome or not. Immediate
postoperative moderate or more residual atrio-ventricular valve insufficiency will eventually require a reoperation, and could be anticipated in
patients younger than 3 months and weighing <4 kg.
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Complete surgical correction of atrio-ventricular septal
defect (AVSD) in infancy is a routine procedure, and early
repair before the onset of irreversible pulmonary hyperten-
sion is mandatory to avoid immediate postoperative and
long-term morbidity. Despite tremendous advances in
technology, surgical technique, and understanding of the
baseline pathophysiology and anatomy of this congenital
heart defect, the results are satisfactory, but have not
drastically improved in the past decade, as can be illustrated
with mortality rates still ranging between 8.7 and 21.7% [1—
5], and reoperation rates of 6.4—16.6% [2—4,6,7].We review
our recent experience with regards to mid-term results and* Corresponding author. Tel.: +41 44 2668020; fax: +41 44 2668021.
E-mail address: ali.dodge-khatami@kispi.uzh.ch (A. Dodge-Khatami).
1010-7940/$ — see front matter # 2008 European Association for Cardio-Thoracic
doi:10.1016/j.ejcts.2008.06.047the rate of reoperation, and the risk factors or pitfalls
influencing the latter.2. Materials and methods
Permission to proceed with this study was granted by the
institutional review board of our hospital. Retrospective
chart review was performed for in-hospital data retrieval,
and follow-up was obtained either by clinical and echocar-
diographic analysis in our own outpatient clinic, or by mail
request of documents from referring pediatric cardiologists.
Between June 2000 and December 2007, 81 consecutive
patients (63% female) underwent primary surgical repair of
complete AVSD in our unit. Patients with associated tetralogy
of Fallot, single papillary muscle, unbalanced ventricles, and
anomalous pulmonary venous connections were excluded.
Two patients had prior coarctation repair through a left
thoracotomy. One small-for-gestational-age newborn withSurgery. Published by Elsevier B.V. All rights reserved.
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Table 1
Patient demographics and results
Age 4.0 months (0.7 months to 9.9 years)
Weight 4.7 kg (2.2—33)
Down syndrome (n) 60
Hospital stay 17 days (8—142)
Complications Chylothorax (n = 9; 11.1%)
Pacemaker (n = 3; 3.7%)
JET (n = 2; 2.5%)
Temporary dialysis (n = 2; 2.5%)
ECMO (n = 2; 2.5%)




Subaortic stenosis resection 1
Mortality n = 3; 3.7%
LAVV: left atrio-ventricular valve insufficiency; RAVV: right atrio-valve insuf-
ficiency; ASD: atrial septal defect; JET: junctional ectopic tachycardia; ECMO:
extracorporeal membrane oxygenation.severe cardiac failure underwent palliative pulmonary artery
banding. Despite our policy to perform elective repair around
4 months of age, our consecutive series contains 13 patients
older than 1 year who either had small restrictive ventricular
septal defects (VSD), mild-to-moderate pulmonary stenosis,
or were referred late. Preoperative pulmonary hypertension,
defined as a systolic pulmonary pressure greater than half-
systolic systemic pressure, was present in 6/21 patients with
normal chromosomes (28.6%), and in 43/60 patients with
Down syndrome (71.7%). Further patient demographics are
given in Table 1.
Surgery was performed through median sternotomy, using
full cardiopulmonary bypass withmoderate hypothermia (26—
32 8C), intermittent anterograde cold blood cardioplegia, and
repair through a right atriotomy. Patch closure was performed
for the atrial septal defect (ASD) in 51.9% of cases (n = 42), and
for closure of the VSD in 85.2% of cases (n = 69). In the
remaining patients, the atrial defects were small enough to be
closed directly, as described by our senior author [8], or the
ventricular defectswere judged to be better closed directly to
simplify repair without division of the common atrio-ventri-
cular valves, as described by Nicholson et al. [9]. Concomitant
repair of the left and right atrio-ventricular valves (RAVVs)was
required in 76 (93.8%) and 57 (70.4%) instances, respectively.
These included not only closure of the clefts in the atrio-
ventricular valves, but also reduction de Vega or partial
annuloplasty sutures, as required. The coronary sinus was
systematically allowed to drain in the right atrium. Intra-
operative transesophageal echocardiography (TEE) was rou-
tine in all cases, allowing for preoperative confirmation of the
anatomy, as well as assessment of the repair at the end of
surgery. In cases of large residual shunts with hemodynamic
significance (>2 mm), or more than moderate atrio-ventri-
cular valve insufficiency, as detected by TEE after weaning
from cardiopulmonary bypass, revision of the repair was
undertaken to correct residual lesions.
2.1. Statistical methods
Data are expressed as mean  standard deviation or
median (range), as appropriate. The end point ‘time toreoperation’ has been analyzed using Kaplan—Meier curves,
and the significance of its relationship with binary factors
(Down/non-Down; weight <4 kg/>4 kg; age at surgery
<3 months/>3 months) has been assessed using log rank
tests. A p value smaller than 0.05 was considered significant.3. Results
Follow-up was complete except for two patients living
abroad, and spanned a median of 28 months (range 0.4
months to 6.1 years). Median cardiopulmonary bypass time
was 140 min (range 58—270 min), and median aortic cross-
clamp time was 82 min (range 32—189 min). Intra-opera-
tively at the end of cardiopulmonary bypass, TEE disclosed a
residual significant (>2 mm) intra-cardiac shunt in five
instances, requiring a second run on cardiopulmonary bypass
to close the residual defect. Also, more than moderate
residual left atrio-ventricular valve (LAVV) insufficiency was
detected by TEE in 13 cases, requiring a second run on bypass
to handle either a residual cleft, or to achieve better leaflet
coaptation with a partial annuloplasty. Postoperatively,
liberal use of an open chest with delayed sternal closure
on the intensive care unit was preferred, and was performed
in nine patients, two of which needed an open chest for
postoperative extracorporeal membrane oxygenation
(ECMO) support. For patients with pulmonary hypertension
and hemodynamic compromise upon weaning from cardio-
pulmonary bypass, liberal postoperative use of inhaled nitric
oxide (maximum 20 ppm)wasmade on the intensive care unit
until subsequent oxygen and ventilator weaning could be
achieved (n = 24). The incidence of postoperative complica-
tions is given in Table 1. The duration of hospitalization
ranged from 8 to 142 days (median 17), and did not vary
significantly between Down (median 17 days; range 8—142)
and non-Down patients (median 14; range 8—118).
There was no intra-operative mortality, but three cases of
in-hospital mortality, all in children with Down syndrome
(3.7%).One patient died 4 days after surgical repair, due to left
ventricular failure, hemorrhagic lung edema, acute renal
insufficiency, hemorrhagic ischemic enterocolitis, and ulti-
mately multi-organ failure. Another required neonatal total
repair at 1 month of age, with a fenestrated ASD and
postoperative ECMO support. Postoperative severe right atrio-
ventricular valve insufficiency warranted right-sided valve
replacement with a 12 mm Contegra bovine jugular vein graft
6 days later, which allowed weaning from ECMO. The patient
eventually died from sepsis and multi-organ failure on
postoperative day 23. Finally, one patient underwent succ-
essful complete AVSD repair with a perfect result as
documented on echocardiography, but developed an acute
and severepulmonary infectionwith respiratory syncytial virus
on postoperative day 10 requiring respiratory ECMO support,
which lasted 9 days until multi-organ failure and pulmonary
superinfection led to ECMO discontinuation and the patient’s
demise. The one late death occurred 2 months after hospital
discharge in a patient with Down syndrome, initially with very
low birth weight and failure to thrive, an initial pulmonary
artery banding followed by complete repair and resection of
subaortic stenosis at the age of 3 months, with a stormy
postoperative course due to interstitial lymphangiectasia of
A. Dodge-Khatami et al. / European Journal of Cardio-thoracic Surgery 34 (2008) 745—750 747
Fig. 2. Freedom from reoperation with regards to age at initial correction.the lungs with concomitant pulmonary hypertension. The
infant died at home, probably subsequent to aspiration, while
still on oxygen supplementation for interstitial lung disease
and a naso-gastric feeding tube.
No or only mild LAVV insufficiency was noted in 81.3% of
patients at last follow-up (61/75). In 14 patients there was
moderate or severe valve dysfunction (18.7%), requiring
reoperation in four cases. At reoperation, a combination of
residual cleft and annular dilatation was encountered, and
accordingly handled with residual cleft closure and/or
reduction de Vega annuloplasty. After redo surgery for LAVV
insufficiency, achieved without mortality, residual moderate
(n = 1) and severe (n = 1) LAVV insufficiency were still present
in two patients, indicating the difficulty in attempting repeat
repair of a dysmorphic valve.
No or only mild RAVV regurgitation was present in 92.1% of
patients at last follow-up (70/76), although 6.6% (5/76) had a
deterioration of their RAVV function in time. Three of them
underwent a reoperation for other indications, with con-
comitant RAVV repair in one case. The other two had no
complications and were medication-free at last follow-up.
One patient required reoperation specifically for right atrio-
ventricular valve insufficiency (1/76; 1.3%), with valve
replacement, as described above, and eventually expired.
Postoperative junctional ectopic tachycardia occurred in
two patients (2.5%), successively treated with patient
cooling and intravenous amiodarone. Third degree heart
block requiring insertion of an epicardial pacemaker system
occurred in three patients (3.7%), and was performed during
the same hospitalization as the complete AVSD repair.
Altogether, reoperation was necessary in seven patients
(7/79; 8.9%), and was performed at a median of 145 days
after initial repair (range 6—510 days). Indications for redo
surgery were LAVV insufficiency (n = 4), right atrio-ventri-
cular valve insufficiency (n = 1), a residual ASD (n = 1), and
subaortic stenosis (n = 1). More than half of the patients
requiring a reoperation had Down syndrome (n = 4). As
illustrated in Fig. 1, although the time to reoperation was
shorter in non-Down patients, non-Down patients did not
reach statistical significance with regards to the need for
reoperation ( p < 0.2). Both younger age (<3 months) andFig. 1. Freedom from reoperation between Down and non-Down patients.lighter weight (<4 kg) were associated with a higher risk for
earlier reoperation ( p = 0.001 and p = 0.003, respectively),
as can be seen in Figs. 2 and 3, respectively. There were no
early or late complications after reoperation for LAVV.
Six small residual ASDs, of which two were intentional
fenestrations, spontaneously closed after a median of 200
days. The intentional fenestrations were left in two patients
with borderline smaller left ventricles, where two-ventricle
repair was judged feasible. In two patients, small residual
ASDs (<2 mm) remained open during follow-up. In three
patients, although no residual ASD was detected on post-
operative echocardiography, a shunt at the atrial level was
detected at last follow-up. The initial repair had been by
direct ASD closure in all three cases, implicating perhaps
excessive tension on the direct closure suture lines at primary
repair, which may have dehisced subsequently. Only one of
these patients required a reoperation for ASD closure owing
to a hemodynamically significant left-to-right shunt.
Nine residual VSDs closed spontaneously after a median of
226 days. In four patients, an initial complete closure or a
small residual VSD defect evolved into a larger residual shunt.Fig. 3. Freedom from reoperation with regards to weight at initial correction.
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the VSD, but for residual LAVV insufficiency, which were
concomitantly addressed during redo surgery.
Four patients (4/75; 5.3%) had evidence of turbulence in
the left ventricular outflow tract after initial repair, which
persisted until last follow-up. Only one of them required redo
surgery for a subaortic stenosis gradient>50 mmHg, consisting
of an uneventful resection of subaortic fibrous tissue, which
has not recurred at last follow-up.4. Discussion
Surgical mortality after AVSD repair varies tremendously
and is institution-dependent, ranging from 3.0 to 21.7% [1—
5]. Our mortality was 3.7%, which compares to these results,
reflecting the overall improvements achieved by many
centers in the more recent era. Postoperative morbidity
and rate of reoperation also vary widely, depending on the
degree of expertise at a given institution. Indications for
reoperation include left or right AVV insufficiency, residual
intracardiac shunts, and subaortic stenosis, whose rate in the
literature varies between 6.4 and 16.6% [2—4,6,7], similar to
that found in our series (10.5%). We found age younger than 3
months ( p = 0.001) and weight less than 4 kg ( p = 0.003) to
be independent risk factors for reoperation. The goal of the
study was to analyze our recent results with a standardized
technique in a consecutive series of patients with relatively
straightforward anatomical variants of AVSD. Therefore,
concomitant anomalies with Fallot-type right outflow
obstruction, single papillary muscle or unbalanced ventricles
leading to single ventricle repair, or other complex anomalies
were excluded in an effort to reduce confounding factors
relevant to survival or reoperation.
4.1. Age and weight at repair
The optimal weight and age at operation has evolved over
time, and is still controversial. Down syndrome is a risk factor
for rapid progression of obstructive pulmonary vascular
disease [10], which justifies the more aggressive approach
towards earlier operative correction in these infants.
Previously, early repair was considered as that up until 6
months of age [7,11,12]. Earlier repair with closure of shunts
and the normalization of hemodynamics improves quality of
life [12] and reduces operative mortality [13]. Currently, it is
generally agreed that pulmonary hypertension develops
earlier,will inevitablyprogress andworsen, andwill negatively
influence perioperative morbidity and perhaps mortality.
Therefore, more centers including our own, are advocating
earlier elective repair around 3—4 months of age. Although
some concern has been raised as to the increased surgical
mortality [3] when repair is performedbefore 6months of age,
this risk factor has been neutralized in the current era in most
centers. In our experience, postoperative residual moderate
or severe LAVV insufficiency was more frequent in patients
when operated upon before 3 months of age. The mean age of
the seven patients requiring reoperations was 2 months, and
occurred in patients with prior intractable heart failure due to
very large intracardiac shunts and/or pre-existing valve
insufficiency. Both the increased fragility of valvar tissuesand the global cardiac dilatation from insufficiency forced us
to operate on these patients at a younger age than the usual
routine at our institution. Because of the potential increased
risk for reoperation in the very young, we maintain our bias
towards early complete repair around 3—4months, in order to
avoid the detrimental effects from ongoing pulmonary hyper-
tension with increasing age, and the added postoperative
morbidity/mortality there unto pertaining.
Studies by Gu¨nther and Prifti [3,14] revealed that weight
less than 5 kg was a predictor for longer postoperative
ventilatory assistance, longer intensive care stay, and need
for reoperation, as compared to larger babies. Contrary to
these findings, Al-Hay et al. [6] found no correlation between
weight and need for reoperation. Our study shows that
infants eventually requiring redo surgery had a lower median
weight at first repair (3.5 kg), compared to the median
weight of the total group (5.9 kg).
4.2. Down syndrome
In our experience, patients with trisomy 21 have a
different atrio-ventricular valve apparatus than non-Down
patients. In Down patients, valve tissue is more abundant,
and allows for an easier reconstruction, leading to fewer
reoperations for LAVV insufficiency. Confirming our impres-
sion, Al-Hay et al. [6] reported that dysplasia of the left atrio-
ventricular valve is more common in non-Down patients, and
thus is the main indication for reoperation in these patients,
a finding also confirmed by others [2,15]. Along the same
lines, Formigari et al. [16] argued a higher prevalence of
recurrent/residual subaortic stenosis in non-Down patients,
and a lower prevalence of reoperation in patients with Down
syndrome. Similarly, Rizzoli et al. [17] described that Down
syndrome was not an independent risk factor for operative
mortality, and that they underwent fewer reoperations.
Somewhat contrary to these findings, some have stated that
Down syndrome is a potential risk factor for hospital and late
death [13,18], as well as for reoperation [13]. We could not
confirm this in our series, albeit our numbers may be too
small to detect significance. Down patients presented more
postoperative non-cardiac complications (16/60; 26.7%) than
non-Down patients (2/21; 9.5%), although this did not
prolong hospital length of stay, which was similar in both
patient groups.
4.3. Left atrio-ventricular valve insufficiency and
reoperation
LAVV insufficiency is the most common indication for
reoperation in patients after complete AVSD repair
[1,3,13,15,19,20], although the degree of insufficiency one
may tolerate is not clear from the extant literature. Pozzi
et al. [13] stated that preoperative valve incompetence was
a significant risk factor for LAVV insufficiency after AVSD
complete repair, and Gu¨nther [3] found that it was even a risk
factor for operative mortality, although others [1,21] refute
these findings. In one study, a lower reoperation rate for LAVV
insufficiency was observed when using the two-patch
technique [15], although we cannot confirm this finding.
Moderate to severe LAVV insufficiency was present in 12/81
(14.8%) of our patients, although only four of these patients
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required reoperation. Despite systematic intra-operative TEE
assessment of repair and the tremendous adjunct it represents
with regards to intra-operative understanding of the mitral
valve apparatus, this echocardiographic diagnostic tool has its
shortcomings, and underestimates the degree of actual LAVV
insufficiency [22]. Our policy is to accept onlymild residual MI,
and togobackoncardiopulmonarybypass to attempt re-repair
of anything more severe. However, we and others [22] have
increasingly noticed that residual LAVV insufficiency is difficult
to quantify intra-operatively using TEE, with a frustrating
discrepancy observed between immediate post-bypass TEE
and the transthoracic echocardiography performed days
to weeks later. Accordingly, we have documented initial
satisfactory repairs of the LAVV intra-operatively, only to
observe a deterioration of LAVV insufficiency after weeks or
months, some of which even required reoperation. This is
mirroredby themajority (4/6) of our patientswho initially had
a fully uneventful and uncomplicated postoperative course
and who eventually went on to require a reoperation. An
uneventful postoperative course is therefore not a surrogate
for a reoperation-free future, and minimal residual or recu-
rring lesionsmay potentially evolve andworsen. None of these
patients had postoperative endocarditis to explain an infec-
tious dehiscence of suture lines in the cleft or patch material.
Reconstruction of recurrent or residual LAVV insufficiency
at reoperation is difficult, as illustrated by two patients in our
series who maintained moderate and severe valve insuffi-
ciency even after attempted redo reconstruction. Therefore,
every effort should be made at the primary complete
correction to avoid residual LAVV insufficiency, with the hope
that it will not recur or worsen with patient growth. Poirier
et al. [7] have described a successful technique to deal with
this difficult issue, with satisfactory results.
4.4. Residual defects
There are few representative studies about residual atrial
and ventricular septal defects. In our study, after primary
surgical repair until last follow-up, 88.9% (72/81) of patients
had no residual septal defects. In their series of 158 patients,
Backer et al. [15] describednopatients requiring a reoperation
for residual shunts. We found only 1/81 patient (1.2%) who
required a reoperation for a significant residual ASD. Nine
small residual VSDs closed spontaneously after amedian of 226
days. Of the four patients with a residual VSD >2 mm, two
underwent a reoperation for concomitant shunt closure with
the primary surgical indication of LAVV valve repair.
Residual or recurrent subaortic stenosis is a potential
critical lesion requiring close follow-up, and eventual
reintervention [4,23]. We found subaortic stenosis in four
patients, in whom one required a second operation. We
surgically address this lesion when the peak gradient reaches
50 mmHg, or with any evidence of aortic valve insufficiency
detected by echocardiography, so as to avoid progressive left
ventricular hypertrophy and further aortic valve damage.
4.5. Arrhythmia and heart block
Our incidences of postoperative JET (2.5%) and complete
heart block requiring a pacemaker (3.7%) are similar to thosefound in the literature [1—6], illustrating the standardized
surgical technique and improvements in intensive care
management one expects in centers experienced with
patients congenital heart disease.5. Conclusion
Complete elective repair of AVSD around 3—4 months of
age, or semi-urgently with a weight >4 kg in the neonatal
period, can be achieved with low mortality rates. The aim is
to restore normal hemodynamics, and avoid the conse-
quences of progressive pulmonary hypertension, without
increasing the risk for reoperation. In the vast majority of
cases, small residual intracardiac shunts (<2 mm) will
spontaneously close in time, and seldom require reinterven-
tion. Intra-operatively, TEE may underestimate mild to
moderate MI, which can deteriorate in time, despite an
uneventful initial postoperative course. Improvements in
intra-operative assessment of repair with regards to the left
atrio-ventricular valve are mandatory, in order to reduce the
incidence of reoperations in the future. Moderate or more
severe residual LAVV insufficiency is the most frequent
indication for reoperation, and is more prevalent in patients
with normal chromosomes, as compared to patients with
Down syndrome.
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